Heart & blood pressure · Detroit area, MI
Heart and blood pressure studies in Detroit area, MI
81 recruiting studies have a site in the Detroit area. This page includes nearby cities such as Ann Arbor, Southfield, Troy, Royal Oak.
81 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions, Inc.
- Location
- Ann Arbor, MI + 46 other US sites
- Eligibility basics
- Ages 18–100
- Recruiting
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
Pulse Biosciences, Inc.
- Location
- Ann Arbor, MI + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Ann Arbor, MI + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- Ann Arbor, MI + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
EmStop Inc
- Location
- Ann Arbor, MI + 6 other US sites
- Eligibility basics
- Ages 22+
- Recruiting
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion
- Location
- Detroit, MI + 31 other US sites
- Eligibility basics
- Ages 21+
- Recruiting
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Versono Medical Ltd
- Location
- Dearborn, MI + 5 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Novo Nordisk A/S
- Location
- Bloomfield Hills, MI + 129 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Ann Arbor, MI + 42 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
DeepQure Inc.
- Location
- Detroit, MI + 5 other US sites
- Eligibility basics
- Ages 22–80
- RecruitingPhase 2
A Trial of CRD-4730 in HFrEF
Cardurion Pharmaceuticals, Inc.
- Location
- Bloomfield Hills, MI + 1 other US site
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Detroit, MI + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Immunovant Sciences GmbH
- Location
- Detroit, MI + 47 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Novartis Pharmaceuticals
- Location
- Troy, MI + 18 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Teleflex
- Location
- Detroit, MI + 9 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The TRICURE EFS Study
TRiCares
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Arga Medtech SA
- Location
- Ann Arbor, MI + 17 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- Royal Oak, MI + 46 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Detroit, MI + 29 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Bay City, MI + 112 other US sites
- Eligibility basics
- Ages 45+
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Detroit, MI + 56 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
SeaStar Medical
- Location
- Ann Arbor, MI
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Ann Arbor, MI + 36 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction
BioCardia, Inc.
- Location
- Detroit, MI + 3 other US sites
- Eligibility basics
- Ages 21–90
Who these studies look for
Many require a diagnosis or specific lab values such as LDL cholesterol or blood pressure readings, and exclude recent heart events.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.